Thymosin-α1 and famciclovir combination therapy activates T cell response in patients with chronic HBV infection in immune tolerant phase.

被引：0
|
作者：
Lau, GK
Nanji, A
Hou, JL
Fong, DY
Yuen, ST
Lai, ST
Leung, YK
Leung, SK
Shiu-Kum, L
机构：
[1] Queen Mary Hosp, Hong Kong, Peoples R China
[2] Nanfang Hosp, Guangzhou, Peoples R China
[3] Clin Trial Ctr, Hong Kong, Peoples R China
[4] Princess Margaret Hosp, Hong Kong, Peoples R China
来源：
HEPATOLOGY | 2001年 / 34卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
610
引用
收藏
页码：324A / 324A
页数：1
相关论文
共 50 条
  • [1] Thymosin-α1 and famciclovir combination therapy activates T-cell response in patients with chronic hepatitis B virus infection in immune-tolerant phase
    Lau, GKK
    Nanji, A
    Hou, J
    Fong, DYT
    Au, WS
    Yuen, ST
    Lin, M
    Kung, HF
    Lam, SK
    JOURNAL OF VIRAL HEPATITIS, 2002, 9 (04) : 280 - 287
  • [2] Mutations in 'B domain' of polymerase gene during combination therapy of Thymosin α1 and Famciclovir in immunotolerant Chinese chronic HBV carriers
    Lau, GKK
    Hou, JL
    Bartholomeusz, A
    Wang, ZH
    Sun, J
    Locarnini, S
    HEPATOLOGY, 1998, 28 (04) : 580A - 580A
  • [3] A Randomized, Controlled Study of Thymosin-α1 Therapy in Patients with Anti-HBe, HBV-DNA-Positive Chronic Hepatitis B
    Claudio Zavaglia
    Remo Severini
    Carmine Tinelli
    Josè S. Franzone
    Aldo Airoldi
    Silvana Tempini
    Giuseppina Bettale
    Gaetano Ideo
    Digestive Diseases and Sciences, 2000, 45 : 690 - 696
  • [4] A randomized, controlled study of thymosin-α1 therapy in patients with anti-HBe, HBV-DNA-positive chronic hepatitis B
    Zavaglia, C
    Severini, R
    Tinelli, C
    Franzone, JS
    Airoldi, A
    Tempini, S
    Bettale, G
    Ideo, G
    DIGESTIVE DISEASES AND SCIENCES, 2000, 45 (04) : 690 - 696
  • [5] A twenty-six-week trial of thymosin α1 plus famciclovir in the treatment of Chinese immune tolerant adult patients with chronic hepatitis B
    Lau, GKK
    Kwok, A
    Karlberg, J
    Lai, ST
    Lim, W
    Leung, YK
    Lam, SK
    ACTA PHARMACOLOGICA SINICA, 1998, 19 : 46 - 46
  • [6] Twenty-six weeks trial of Thymosin α 1 plus Famciclovir in the treatment of Chinese immune tolerant adult patients with chronic hepatitis B
    Lau, GKK
    Kwok, A
    Karlberg, J
    Lai, ST
    Lim, W
    Leung, YK
    Lam, SK
    HEPATOLOGY, 1998, 28 (04) : 216A - 216A
  • [7] REDUCED T CELL ACTIVATION, REGULATORY T CELL MEDIATED SUPPRESSION AND COMPROMISED NATURAL KILLER CELL FUNCTION CHARACTERIZE IMMUNE TOLERANT PHASE OF CHRONIC HBV INFECTION
    Nandi, M.
    Pal, S.
    Ray, G.
    Das, K.
    Ghosh, S.
    Banerjee, S.
    Santra, A.
    Chowdhury, A.
    Datta, S.
    JOURNAL OF HEPATOLOGY, 2015, 62 : S502 - S502
  • [8] A CLINICAL TRIAL ON ANTI-HBV-DC VACCINE COMBINED WITH LAMIVUDINE AND THYMOSIN-α1 IN THE HBeAg POSITIVE PATIENTS OF CHRONIC HEPATITIS B VIRUS INFECTION
    Wu, B. -F.
    Yang, J. -Y.
    Zhang, Y. -L.
    Liu, Y.
    Zhou, H. -H.
    Wang, X. -Q.
    Li, F. -Q.
    Hou, C. -Q.
    Li, X. -S.
    Huang, X. -H.
    Xiao, Z. -S.
    Yang, M.
    Lin, F. -X.
    Fu, Y. -P.
    Zheng, S.
    Chen, W.
    Zhou, Y.
    Yang, J.
    Wan, X. -H.
    Huang, H.
    JOURNAL OF HEPATOLOGY, 2013, 58 : S318 - S318
  • [9] TNF-α partially abrogates regulatory T cell mediated suppression of the anti-HBV immune response in patients with a chronic infection
    Stoop, J. N.
    Biesta, P. J.
    Kusters, J. G.
    Kuipers, E. J.
    Janssen, H. L. A.
    van der Molen, R. G.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2007, 19 (10) : A62 - A62
  • [10] TNF-α partially abrogates regulatory T cell mediated suppression of the anti-HBV immune response in patients with a chronic infection
    Stoop, Jeroen N.
    Biesta, Paula J.
    Kusters, Johannes G.
    Kuipers, Ernst J.
    Janssen, Harry L.
    van der Molen, Renate G.
    HEPATOLOGY, 2006, 44 (04) : 546A - 546A
12345